November 9, 2005 - Miami - For developing the GeneSifter microarray analysis system, VizX Labs today received the 2005 Frost & Sullivan "Best Practices Award for Product Innovation" in its Bioinformatics in Drug Discovery category. The Award was presented at the 2005 Excellence in Best Practices Awards Banquet in Miami, Florida. In presenting the award, Frost & Sullivan called GeneSifter "a uniquely accessible product solution that stands apart from its competitors."

The award comes on the heels of the company's most successful month yet. September was a record sales month, doubling the next best month in the company's history. Recent weeks have seen sales of GeneSifter to major research institutions across the world including commercial research organizations such as Johnson & Johnson and Isis Pharmaceuticals, as well as non-profit groups such as the Huntsman Cancer Institute, the Cleveland Clinic Foundation, Maine Medical Center, and the Tokyo Medical University.

"Celebrating this achievement is an appropriate capstone to a remarkably successful period for VizX," said CEO Tom Ranken, "and an excellent launch point for what we expect to be an even more successful finish to the year. Microarray scientists can get to experimental answers with GeneSifter in a fraction of the time that any other system requires."

About GeneSifter
GeneSifter software helps researchers derive biological understanding from gene expression patterns in microarray data. The web-based system recently received the distinction of "GeneChip-compatible™" from microarray leader Affymetrix. Customer comments are available online at www.genesifter.net/web/labtestimonials.html. Downloadable graphics, including screenshots of the GeneSifter Lab Edition and the new GeneSifter Core Edition, may be viewed online at www.vizxlabs.com/downloadable_images.html.

About VizX Labs
VizX Labs' GeneSifter software helps life scientists Understand the Biology™ revealed through data from microarray experiments. Featured in Wired News and Nature Methods, selected as a Northwest Venture All-Star company and named by Bio-IT World as one of six "bioinformatics youngbloods" remaking that field, VizX was listed by Washington CEO as one of the state's top 25 biotechnology and biomedical companies. To view the VizX Labs newsroom, please visit www.vizxlabs.com/newsroom.html.